Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression.
作者信息
Miller Andrew H
机构信息
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
出版信息
Neuropsychopharmacology. 2013 Aug;38(9):1607-8. doi: 10.1038/npp.2013.140.
Abstract
摘要
相似文献
1
Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression.概念融合：犬尿氨酸途径作为氯胺酮的共同靶点以及抑郁症炎症假说与谷氨酸假说的趋同
Neuropsychopharmacology. 2013 Aug;38(9):1607-8. doi: 10.1038/npp.2013.140.
2
NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.氯胺酮阻断 NMDA 受体可消除 C57BL/6J 小鼠脂多糖诱导的抑郁样行为。
Neuropsychopharmacology. 2013 Aug;38(9):1609-16. doi: 10.1038/npp.2013.71. Epub 2013 Mar 19.
3
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.氯胺酮快速起效的抗抑郁作用机制是什么？对大量惊人可能性的简要概述。
J Clin Pharm Ther. 2017 Apr;42(2):147-154. doi: 10.1111/jcpt.12497. Epub 2017 Jan 22.
4
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive -Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.强效选择性代谢型谷氨酸（mGlu）2/3受体拮抗剂LY3020371与非竞争性N-甲基-D-天冬氨酸受体拮抗剂氯胺酮在啮齿动物中的比较效应：支持使用mGlu2/3拮抗剂治疗抑郁症的证据
J Pharmacol Exp Ther. 2017 Apr;361(1):68-86. doi: 10.1124/jpet.116.238121. Epub 2017 Jan 30.
5
Ketamine and depression.氯胺酮与抑郁症
Br J Anaesth. 2018 Dec;121(6):1198-1202. doi: 10.1016/j.bja.2018.08.020. Epub 2018 Oct 12.
6
Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression.放线菌和柯里氏菌在炎症模型抑郁症中氯胺酮抗抑郁作用的作用。
Pharmacol Biochem Behav. 2019 Jan;176:93-100. doi: 10.1016/j.pbb.2018.12.001. Epub 2018 Dec 5.
7
Cracking the moody brain: lifting the mood with ketamine.破解喜怒无常的大脑：用氯胺酮改善情绪。
Nat Med. 2010 Dec;16(12):1384-5. doi: 10.1038/nm1210-1384.
8
Blocking NMDA receptor at rest: a possible alleviation of depression.静息时阻断N-甲基-D-天冬氨酸受体：一种缓解抑郁症的可能方法。
Acta Pharmacol Sin. 2011 Sep;32(9):1087-8. doi: 10.1038/aps.2011.113. Epub 2011 Aug 1.
9
Depression: comfortably numb.抑郁：麻木得自在。
Nature. 2006 Oct 12;443(7112):629-31. doi: 10.1038/443629a.
10
Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.氯胺酮和 N-甲基-D-天冬氨酸对利用强迫游泳试验诱导的氟西汀抗抑郁相关行为的影响。
Neurosci Lett. 2014 Apr 30;566:172-6. doi: 10.1016/j.neulet.2014.01.015. Epub 2014 Feb 12.
引用本文的文献
1
Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in Octogenarians.八旬老人高身体功能与低身体功能的血清蛋白质组学和代谢组学特征
Aging Cell. 2025 Mar 10;24(5):e70002. doi: 10.1111/acel.70002.
2
Protocol for teen inflammation glutamate emotion research (TIGER): Toward predictors of treatment response and clinical course in depressed adolescents.青少年炎症性谷氨酸与情绪研究方案（TIGER）：探寻青少年抑郁症治疗反应和临床病程的预测因素
Brain Behav Immun Health. 2023 Dec 20;35:100718. doi: 10.1016/j.bbih.2023.100718. eCollection 2024 Feb.
3
Inflammation, stress and depression: An exploration of ketamine's therapeutic profile.炎症、应激和抑郁：氯胺酮治疗作用的探索。
Drug Discov Today. 2023 Apr;28(4):103518. doi: 10.1016/j.drudis.2023.103518. Epub 2023 Feb 8.
4
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.氯胺酮和血清素能致幻剂：快速抗抑郁治疗作用机制和生物标志物的最新研究进展。
Neuropharmacology. 2023 Mar 15;226:109422. doi: 10.1016/j.neuropharm.2023.109422. Epub 2023 Jan 13.
5
Chronic Unpredictable Stress Alters Brain Tryptophan Metabolism and Impairs Working Memory in Mice without Causing Depression-Like Behaviour.慢性不可预测应激改变小鼠大脑色氨酸代谢并损害工作记忆，且不引起类似抑郁的行为。
Neurol Neurobiol (Tallinn). 2021;4(3). doi: 10.31487/j.nnb.2021.03.03. Epub 2021 Sep 25.
6
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration.抗抑郁剂量氯胺酮给药后人类血浆和脑脊液以及小鼠血浆和脑中的比较代谢组学分析。
Transl Psychiatry. 2022 May 2;12(1):179. doi: 10.1038/s41398-022-01941-x.
7
Depression, Estrogens, and Neuroinflammation: A Preclinical Review of Ketamine Treatment for Mood Disorders in Women.抑郁症、雌激素与神经炎症：氯胺酮治疗女性情绪障碍的临床前综述
Front Psychiatry. 2022 Jan 18;12:797577. doi: 10.3389/fpsyt.2021.797577. eCollection 2021.
8
Novel Probable Glance at Inflammatory Scenario Development in Autistic Pathology.对自闭症病理中炎症情况发展的新颖可能见解。
Front Psychiatry. 2021 Dec 22;12:788779. doi: 10.3389/fpsyt.2021.788779. eCollection 2021.
9
Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases.病例报告：难治性抑郁症患者重复系列氯胺酮输注：五例病例展示
Front Psychiatry. 2021 Dec 2;12:705190. doi: 10.3389/fpsyt.2021.705190. eCollection 2021.
10
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency.针对抑郁症中的炎症：氯胺酮作为精神科急诊中的抗炎性抗抑郁药。
Brain Behav Immun Health. 2021 Nov 10;18:100383. doi: 10.1016/j.bbih.2021.100383. eCollection 2021 Dec.
本文引用的文献
1
NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.氯胺酮阻断 NMDA 受体可消除 C57BL/6J 小鼠脂多糖诱导的抑郁样行为。
Neuropsychopharmacology. 2013 Aug;38(9):1609-16. doi: 10.1038/npp.2013.71. Epub 2013 Mar 19.
2
Connecting inflammation with glutamate agonism in suicidality.将炎症与谷氨酸激动作用联系起来以探讨自杀行为。
Neuropsychopharmacology. 2013 Apr;38(5):743-52. doi: 10.1038/npp.2012.248. Epub 2012 Dec 3.
3
Signaling pathways underlying the rapid antidepressant actions of ketamine.氯胺酮快速抗抑郁作用的信号通路。
Neuropharmacology. 2012 Jan;62(1):35-41. doi: 10.1016/j.neuropharm.2011.08.044. Epub 2011 Sep 2.
4
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?严重抑郁症与前扣带回皮质亚区小胶质细胞喹啉酸增加有关：免疫调节谷氨酸能神经传递的证据？
J Neuroinflammation. 2011 Aug 10;8:94. doi: 10.1186/1742-2094-8-94.
5
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.迈向抑郁谷氨酸假说：心境障碍神经精神药理学的新兴前沿。
Neuropharmacology. 2012 Jan;62(1):63-77. doi: 10.1016/j.neuropharm.2011.07.036. Epub 2011 Aug 3.
6
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.炎症及其相关问题：细胞因子在重度抑郁症病理生理学中的作用
Biol Psychiatry. 2009 May 1;65(9):732-41. doi: 10.1016/j.biopsych.2008.11.029. Epub 2009 Jan 15.
Zotero 插件